Myocarditis;Myokarditis

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 50 SUPPL. 8, 2008, Pages

  Sehultheiss, Heinz Peter ^a   Kuhl U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Giant cells; Immunomodulating treatment; Inflammatory cardiomyopathie; Myocardial biopsy; Myocarditis

Indexed keywords

ANTHRACYCLINE; ANTIRHEUMATIC AGENT; ARSENIC; CATECHOLAMINE; CEPHALOSPORIN; CLOZAPINE; COCAINE; CYTOKINE; IMMUNOMODULATING AGENT; LITHIUM; PENICILLIN G; SULFONAMIDE; TOXIN; TRICYCLIC ANTIDEPRESSANT AGENT; TROPONIN T;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CARDIOMYOPATHY; DIAGNOSTIC PROCEDURE; DRUG HYPERSENSITIVITY; ELECTROCARDIOGRAM; GIANT CELL; HEART MUSCLE BIOPSY; HUMAN; HYPOTHERMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR BIOLOGY; MYOCARDITIS; PARASITOSIS; PROTOZOAL INFECTION; REVIEW; VIRUS DETECTION; VIRUS INFECTION;

BIOPSY; HUMANS; MYOCARDITIS; MYOCARDIUM;

EID: 57849105198     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100964     Document Type: Review

References (22)

1. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006; 113: 593-595
2. Bowles NE, Ni J, Kearney DL et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466-472
3. Caforio AL, Calabrese F, Angelini A et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007; 28: 1326-1333
4. Cooper LTJr, Berry GJ, Rizeq M, Schroeder JS. Giant cell myocarditis. J Heart Lung Transplant 1995; 14: 394-401
5. Dec GWJr, Palacios IF, Fallon JT et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-890
6. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-1398
7. Felker GM, Thompson RE, Hare JM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084
8. Frustaci A, Chimenti C, Calabrese F et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863
9. Frustaci A. Europ Heart J 2008. Abstract (European Heart Congress München)
10. Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008; 246: 401-409
11. Holzmann M, Nicko A, Kühl U et al. Complication rate in right ventricular endomyocardial biopsy - A retro- and prospective study over a 11 year period analyzing 3048 diagnostic procedures. Circulation, 2008; in press
12. Kühl U, Lassner D, Pauschinger M et al. Detection and Prevalence of Erythrovirus Genotypes in the Myocardium of Patients With Dilated Cardiomyopathy. J Med Virol, 2008: in press
13. Kühl U, Pauschinger M, Noutsias M et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005; 111: 887-893
14. Kühl U, Pauschinger M, Schwimmbeck PL et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003; 107: 2793-2798
15. Mangnani JW, Suk Danik HJ, Dec GW, DiSalvo TG. Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathological, clinical, and hemodynamic predictors. Am Heart J 2006; 151: 463-470
16. Mason JW, O'Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-275
17. rd, Boehmer JP, Hruban RH et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695
18. Pauschinger M, Doerner A, Kuehl U et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999; 99: 889-895
19. Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al. Detection of ade-noviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999; 99: 1348-54
20. Schultheiss HP, Kuhl U. [State of diagnostics and therapy of inflammatory cardiomyopathie]. Internist (Berl) 2008; 49: 7-16
21. Why HJ, Meany BT, Richardson PJ et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994; 89: 2582-2589
22. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104: 39-45